Elevated Fibroblast Growth Factor 23 in Women With Malignant Ovarian Tumors
Tebben P, Kalli K, Cliby W, Hartmann L, Grande J, Singh R, Kumar R. Elevated Fibroblast Growth Factor 23 in Women With Malignant Ovarian Tumors. Mayo Clinic Proceedings 2005, 80: 745-751. DOI: 10.4065/80.6.745.Peer-Reviewed Original ResearchAdvanced-stage ovarian cancerEarly-stage ovarian cancerOvarian cancerFibroblast growth factor 23FGF23 concentrationsPlasma FGF23 concentrationCFGF23 concentrationsSerum iFGF23Ovarian tumorsHealthy womenAdvanced-stage epithelial ovarian cancerMalignant ovarian cancer cellsElevated fibroblast growth factor 23Benign ovarian tumorsMalignant ovarian tumorsAdvanced-stage diseaseEpithelial ovarian cancerAdvanced-stage tumorsOvarian cancer cellsStage of diseaseSerum phosphate concentrationSerum FGF23 concentrationsOvarian massBenign diseaseSerum phosphorusElevated fibroblast growth factor 23 in women with malignant ovarian tumors.
Tebben P, Kalli K, Cliby W, Hartmann L, Grande J, Singh R, Kumar R. Elevated fibroblast growth factor 23 in women with malignant ovarian tumors. Mayo Clinic Proceedings 2005, 80: 745-51. PMID: 15948297, DOI: 10.1016/s0025-6196(11)61528-0.Peer-Reviewed Original ResearchConceptsAdvanced-stage ovarian cancerEarly-stage ovarian cancerOvarian cancerFGF23 concentrationsPlasma FGF23 concentrationCFGF23 concentrationsSerum iFGF23Ovarian tumorsHealthy womenMalignant ovarian cancer cellsMalignant ovarian tumorsBenign ovarian tumorsAdvanced-stage diseaseAdvanced-stage tumorsFibroblast growth factor 23Elevated fibroblast growth factorOvarian cancer cellsSerum phosphate concentrationStage of diseaseSerum FGF23 concentrationsOvarian massBenign diseaseSerum phosphorusBenign massesMayo Clinic